Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 3,253-3,264 of 10,592
Drug study icon
TerminatedNCT05254405

An Open Label Study of IV Brexanolone for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
Donald Jeffrey Newport
Condition
PTSD
Drug study icon
CompletedNCT01666119

Safety study of BEMA® Buprenorphine NX in Addiction

This study is completed in the United States. It is testing BEMA® Buprenorphine NX for Addiction.

In United States
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
BioDelivery Sciences International
Condition
Addiction
Device study icon
CompletedNCT02640950

An Open Label study of TMS Therapy for Depression in bipolarity

This study exists to understand whether the medication TMS is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication TMS can give earlier or clearer feedback during care.

In United States
Bipolarity, DepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Bipolarity, Depression
Drug study icon
TerminatedNCT01139125

An Open study of Cysteamine Treatment in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Augusta University
Condition
Schizophrenia
Drug study icon
Enrolling By InvitationNCT07161700

Safety study of SPT-300 (GlyphAllo) in depression

This study is enrolling by invitation in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.

In United States
DepressionDrugFrom 18 Years to 66 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Seaport Therapeutics
Condition
Depression
Drug study icon
CompletedNCT03861338

Sublocade for Addiction

This study is completed in the United States. It is testing sublocade for Addiction.

In United States
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.